A clinically applicable and scalable method to regenerate T-cells from iPSCs for off-the-shelf T-cell immunotherapy
T-cell immunotherapies, such as CAR-T immunotherapy, are being developed against a wide variety of diseases. Here the authors report the feeder-free, scalable differentiation of human induced pluripotent cells (iPSCs) to T-cells with T-cell receptor dependent anti-tumour function in vitro and in viv...
Enregistré dans:
Auteurs principaux: | Shoichi Iriguchi, Yutaka Yasui, Yohei Kawai, Suguru Arima, Mihoko Kunitomo, Takayuki Sato, Tatsuki Ueda, Atsutaka Minagawa, Yuta Mishima, Nariaki Yanagawa, Yuji Baba, Yasuyuki Miyake, Kazuhide Nakayama, Maiko Takiguchi, Tokuyuki Shinohara, Tetsuya Nakatsura, Masaki Yasukawa, Yoshiaki Kassai, Akira Hayashi, Shin Kaneko |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/12a17ede1fbe4df1bb06b871dd8b9d04 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Microhomology-assisted scarless genome editing in human iPSCs
par: Shin-Il Kim, et autres
Publié: (2018) -
Dissecting transcriptomic signatures of neuronal differentiation and maturation using iPSCs
par: Emily E. Burke, et autres
Publié: (2020) -
Efficient manipulation of gene dosage in human iPSCs using CRISPR/Cas9 nickases
par: Tao Ye, et autres
Publié: (2021) -
Genetic aberrations in iPSCs are introduced by a transient G1/S cell cycle checkpoint deficiency
par: Ryoko Araki, et autres
Publié: (2020) -
Modeling of lung phenotype of Hermansky–Pudlak syndrome type I using patient-specific iPSCs
par: Takahiro Suezawa, et autres
Publié: (2021)